AI may speed up search for drugs to treat brain conditions
Researchers hope the work will help identify affordable, effective drugs to treat conditions like MND.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
Researchers hope the work will help identify affordable, effective drugs to treat conditions like MND.
Researchers are deploying AI systems to scan thousands of existing drugs, aiming to identify candidates for brain conditions in years instead of decades, potentially transforming the search for treatments for diseases like motor neurone disease (MND).
Researchers are leveraging artificial intelligence to speed up the search for affordable, effective drugs for brain conditions such as motor neurone disease (MND), potentially reducing development timelines and costs.
Scientists are using artificial intelligence to speed up the search for brain drugs that may already exist but have not been fully explored for neurological conditions, potentially cutting discovery timelines from decades to just a few years.
Researchers are leveraging artificial intelligence to expedite the identification of affordable, effective drugs for challenging brain conditions, including Motor Neuron Disease (MND), potentially marking a significant shift in neurological drug development.
Scientists are using AI to accelerate the search for treatments for neurological conditions, analyzing patient data to identify whether existing drugs could be repurposed to treat conditions such as motor neurone disease (MND).
Scientists are using AI to expedite drug development, uncovering treatments for neurological conditions that may be hiding in plain sight, including motor neurone disease (MND).
Similar Stories
Related coverage based on topic and tags
Biogen's Alzheimer's drug lowers toxic protein, but results were mixed - Reuters
Biogen's Alzheimer's drug lowers toxic protein, but results were mixed Reuters
July 14, 2026 at 04:17 PMFDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug - Reuters
FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug Reuters
July 13, 2026 at 08:59 PMHow Indian scientists are mapping the brain's last frontier
India's new brainstem atlas offers scientists an unprecedented map of one of the brain's least known regions.
July 13, 2026 at 12:08 AMOver 200 experts call for urgent action to tackle AI's economic impact - Reuters
Over 200 experts call for urgent action to tackle AI's economic impact Reuters
July 13, 2026 at 11:07 AMAI is 'not smart' so what's next in artificial intelligence?
Leading AI researcher Yan LeCun has a start-up which is developing a more flexible AI system.
July 2, 2026 at 11:02 PMAI cloud company CoreWeave explores Wall Street playbook to hedge memory-chip price risk - Reuters
AI cloud company CoreWeave explores Wall Street playbook to hedge memory-chip price risk Reuters
July 14, 2026 at 11:51 PM